Search Results - "Heroux, Alain L"

  • Showing 1 - 15 results of 15
Refine Results
  1. 1

    Serine-910 phosphorylation of focal adhesion kinase is critical for sarcomere reorganization in cardiomyocyte hypertrophy by Chu, Miensheng, Iyengar, Rekha, Koshman, Yevgeniya E., Kim, Taehoon, Russell, Brenda, Martin, Jody L., Heroux, Alain L., Robia, Seth L., Samarel, Allen M.

    Published in Cardiovascular research (01-12-2011)
    “…Aims Tyrosine-phosphorylated focal adhesion kinase (FAK) is required for the hypertrophic response of cardiomyocytes to growth factors and mechanical load, but…”
    Get full text
    Journal Article
  2. 2
  3. 3

    The Value of Psychosocial Factors in Patient Selection and Outcomes after Heart Transplantation by Coglianese, Erin E., Samsi, Mekhala, Liebo, Max J., Heroux, Alain L.

    Published in Current heart failure reports (01-02-2015)
    “…Heart transplantation remains the gold standard treatment for advanced heart failure, although its use is limited by donor organ availability. To ensure that…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Utility of screening computed tomography of chest, abdomen and pelvis in patients after heart transplantation by Dasari, Tarun W, Pavlovic-Surjancev, Biljana, Dusek, Linda, Patel, Nilamkumar, Heroux, Alain L

    Published in European journal of radiology (01-12-2011)
    “…Abstract Introduction Malignancy is a late cause of mortality in heart transplant recipients. It is unknown if screening computed tomography scan would lead to…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy by HEROUX, A. L, SILVERMAN, P, KAO, W. G, JOHNSON, S. A, COSTANZO, M. R, O'SULLIVAN, E. J, JOHNSON, M. R, YOULIAN LIAO, MCKIERNAN, T. L, BALHAN, J. E, LEYA, F. S, MULLEN, G. M

    Published in Circulation (New York, N.Y.) (1994)
    “…The diffuse nature of cardiac allograft vasculopathy makes early detection of the disease by traditional noninvasive methods or coronary angiography difficult…”
    Get full text
    Journal Article
  8. 8

    High-risk cardiac operation: A viable alternative to heart transplantation by Johnson, Maryl R., Costanzo-Nordin, Maria Rosa, Heroux, Alain L., Kao, Walter G., Mullen, G.Martin, Pifarré, Roque, Sullivan, Henry J.

    Published in The Annals of thoracic surgery (01-04-1993)
    “…To determine if high-risk heart operation with circulatory support standby is an acceptable alternative to direct heart transplantation, we reviewed 21…”
    Get full text
    Journal Article
  9. 9

    Abdominal aortic aneurysms (AAA) post heart transplantation: a systematic review of literature by Dasari, Tarun, Heroux, Alain, Peyton, Marvin, Saucedo, Jorge

    Published in Annals of transplantation (01-07-2011)
    “…Peripheral vascular disease is highly prevalent post heart transplantation (HTx). The prevalence of abdominal aortic aneurysms (AAA) post HTx ranges from…”
    Get full text
    Journal Article
  10. 10

    Successful treatment of heart transplant rejection with photopheresis by Costanzo-Nordin, M R, Hubbell, E A, O'Sullivan, E J, Johnson, M R, Mullen, G M, Heroux, A L, Kao, W G, McManus, B M, Pifarre, R, Robinson, J A

    Published in Transplantation (01-04-1992)
    “…Photopheresis is a potential therapy for rejection in which reinfusion of mononuclear cells exposed to ultraviolet-A light ex vivo, after treatment with…”
    Get more information
    Journal Article
  11. 11

    Photopheresis versus corticosteroids in the therapy of heart transplant rejection. Preliminary clinical report by Costanzo-Nordin, M R, Hubbell, E A, O'Sullivan, E J, Johnson, M R, Mullen, G M, Heroux, A L, Kao, W G, McManus, B M, Pifarre, R, Robinson, J A

    Published in Circulation (New York, N.Y.) (01-11-1992)
    “…Photopheresis is a technique in which reinfusion of mononuclear cells exposed to UV-A light ex vivo after in vivo treatment with 8-methoxypsoralen initiates…”
    Get full text
    Journal Article
  12. 12

    Does heart transplantation confer additional benefit over medical therapy to patients who have waited >6 months for heart transplantation? by Kao, Walter, McGee, Dan, Liao, Youlian, Heroux, Alain L., Mullen, George M., Johnson, Maryl R., Costanzo, Maria Rosa

    “…Objectives. This study compared the survival of patients with heart failure who have waited > 6 months for heart transplantation with that of patients who…”
    Get full text
    Journal Article
  13. 13

    Risk/benefit ratio of perioperative OKT3 in cardiac transplantation by Johnson, Maryl R., Mullen, G. Martin, O'Sullivan, E. Jeanne, Liao, Youlian, Heroux, Alain L., Kao, Walter G., Pifarre, Roque, Costanzo, Maria Rosa

    Published in The American journal of cardiology (01-08-1994)
    “…To evaluate the risk/benefit ratio of perioperative OKT3 in cardiac transplant patients receiving triple-drug immunosuppression, patients who underwent cardiac…”
    Get full text
    Journal Article
  14. 14

    Factors associated with the development of persistently depressed cardiac output during the first year after cardiac transplantation by Glazier, J J, Mullen, G M, Johnson, M R, Lung, C T, Heroux, A L, Kao, W G, Koch, D, Khatib, Y, Fisher, S G, Costanzo, M R

    Published in Clinical cardiology (Mahwah, N.J.) (01-09-1994)
    “…The purpose of this study was to determine factors associated with the development of a persistently depressed cardiac output during the first year after…”
    Get more information
    Journal Article
  15. 15